Patents Assigned to EDIGENE THERAPEUTICS (BEIJING) INC.
  • Patent number: 11702658
    Abstract: The present application provides methods for editing RNA by introducing a deaminase-recruiting RNA in a host cell for deamination of an adenosine in a target RNA. The present application further provides deaminase-recruiting RNAs used in the RNA editing methods and compositions comprising the same.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: July 18, 2023
    Assignees: EDIGENE THERAPEUTICS (BEIJING) INC., PEKING UNIVERSITY
    Inventors: Pengfei Yuan, Yanxia Zhao, Nengyin Liu, Zexuan Yi, Gangbin Tang, Wensheng Wei, Liang Qu, Zongyi Yi, Shiyou Zhu, Chunhui Wang, Zhongzheng Cao, Zhuo Zhou